Sort   by:  
 Page size 
UnknownRandomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.
Not available
S-EPMC3397694 | biostudies-literature
UnknownPointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Not available
S-EPMC4881367 | biostudies-literature
UnknownPooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
Not available
S-EPMC7845943 | biostudies-literature
Unknownnab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.
Not available
S-EPMC5679693 | biostudies-literature
UnknownFirst-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Not available
S-EPMC6487310 | biostudies-literature
Sort   by:  
 Page size